EP0000679A1 - Verfahren zur Herstellung von Glafenin - Google Patents

Verfahren zur Herstellung von Glafenin Download PDF

Info

Publication number
EP0000679A1
EP0000679A1 EP78400060A EP78400060A EP0000679A1 EP 0000679 A1 EP0000679 A1 EP 0000679A1 EP 78400060 A EP78400060 A EP 78400060A EP 78400060 A EP78400060 A EP 78400060A EP 0000679 A1 EP0000679 A1 EP 0000679A1
Authority
EP
European Patent Office
Prior art keywords
quinoline
glycerol
glyceryl
anthranilate
glafenine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP78400060A
Other languages
English (en)
French (fr)
Other versions
EP0000679B1 (de
Inventor
Sylvano Casadio
Henri Dr. Cousse
Pierre Hascoet
Gilbert Dr. Mouzin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Publication of EP0000679A1 publication Critical patent/EP0000679A1/de
Application granted granted Critical
Publication of EP0000679B1 publication Critical patent/EP0000679B1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms

Definitions

  • the present invention carried out at the Pierre FABRE Research Center relates to a new process for the preparation of the ⁇ -monoglyceride of 4 (2'-carboxyphenylamino) -7-chloro-quinoline of formula:
  • This chemical compound is known for its analgesic properties; it is used as an active ingredient in many pharmaceutical specialties. This molecule will be mentioned below by its international common name glafenine.
  • Glafenine (I) is prepared by condensation in hydrochloric medium of 4,7-dichloro-quinoline (II) with methyl anthranilate (III), this intermediate methyl ester is then transesterified by glycerol acetonide (V) and finally acid hydrolysis of compound (VI) leads to glafenine (I) according to the reaction scheme:
  • the present invention relates to a very simple process which makes it possible to prepare glafenine under very economical conditions.
  • glafenine is prepared by condensation of the glyceryl anthranilate of formula: on 4,7-dichloro-quinoline:
  • This condensation is preferably carried out in a hydrochloric medium.
  • the glafenine obtained is separated from the reaction medium by known methods, it can in particular be precipitated by neutralization of the reaction medium.
  • the crude glafenine obtained can be purified for example by recrystallization from a solvent or mixture of organic solvent such as the chloroform-ethanol mixture.
  • the glyceryl anthranilate is preferably prepared by condensation of glycerol on isatoic anhydride in basic medium as a condensing agent.
  • This process is preferably carried out using an excess of glycerol as solvent, so the glyceryl anthranilate is obtained in solution in glycerol and this solution can be used in the process according to the present invention without having to isolate the anthranilate, which further improves the overall yield of the process.
  • This process for the preparation of glafenine has the advantage of using only products widely available commercially and inexpensively.
  • isatoic anhydride which is experiencing industrial development as a synthesis intermediary in the dye industry can, thanks to new synthesis processes, be obtained at prices much lower than the prices of anthranilic acid which constitutes the basic product in known syntheses of glafenine.
  • this synthetic method makes it possible to significantly increase the yields of glafenine compared to known methods, in particular by limiting the number of reaction steps.
  • reaction medium is then cooled to 20 ° C. and transferred to a 200 l tank in which it is treated slowly with 60 l of an aqueous sodium hydroxide solution N, then the neutralization is completed by adding sodium bicarbonate.
  • the precipitate is separated as previously by wringing; the crude glafenine thus obtained has, after drying, a melting point of 163 ° C.
  • glafenine is obtained with a yield varying according to the case from 65 to 75% compared to 4,7-dichloro-quinoline with an instant melting point at the Kofler block of 169-170 ° C.
  • the residual chloroform content is less than 1,000 ppm.
  • the present invention also relates, as a medicament, to glafenin obtained by implementing the method according to the present invention.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
EP78400060A 1977-07-26 1978-07-18 Verfahren zur Herstellung von Glafenin Expired EP0000679B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7722900A FR2398733A1 (fr) 1977-07-26 1977-07-26 Nouveau procede de preparation de la glafenine
FR7722900 1977-07-26

Publications (2)

Publication Number Publication Date
EP0000679A1 true EP0000679A1 (de) 1979-02-07
EP0000679B1 EP0000679B1 (de) 1981-06-24

Family

ID=9193813

Family Applications (1)

Application Number Title Priority Date Filing Date
EP78400060A Expired EP0000679B1 (de) 1977-07-26 1978-07-18 Verfahren zur Herstellung von Glafenin

Country Status (7)

Country Link
EP (1) EP0000679B1 (de)
JP (1) JPS5424881A (de)
CA (1) CA1107737A (de)
DE (1) DE2860803D1 (de)
ES (1) ES472072A1 (de)
FR (1) FR2398733A1 (de)
IT (1) IT1156878B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549830A1 (fr) * 1983-07-25 1985-02-01 Corbiere Jerome Nouveau procede d'obtention de quinoleines substituees

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHIMIE THERAPEUTIQUE, 1, 65-70 (1966) *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549830A1 (fr) * 1983-07-25 1985-02-01 Corbiere Jerome Nouveau procede d'obtention de quinoleines substituees

Also Published As

Publication number Publication date
CA1107737A (fr) 1981-08-25
DE2860803D1 (en) 1981-10-01
IT1156878B (it) 1987-02-04
EP0000679B1 (de) 1981-06-24
IT7850438A0 (it) 1978-07-24
FR2398733B1 (de) 1980-02-29
ES472072A1 (es) 1979-03-16
JPS5424881A (en) 1979-02-24
FR2398733A1 (fr) 1979-02-23

Similar Documents

Publication Publication Date Title
EP0607952B1 (de) Verfahren zur Herstellung von 5-Aminolävulinsäure
FR2515184A1 (fr) Syntheses de derives de la codeine et autres 3-o-alkylmorphines et composes intermediaires utilises
JPH0753462A (ja) ジアセラインの製造プロセス
EP0000679B1 (de) Verfahren zur Herstellung von Glafenin
BE881862A (fr) Composes antibacteriens et inhibiteurs de beta-lactamase, procede pour les preparer et leur usage comme medicaments
RU2026284C1 (ru) Способ получения сложных алкиловых эфиров 3-хлорантраниловой кислоты
US4970336A (en) Method of purifying α-substituted acetic acids
EP0000678B1 (de) Synthesezwischenprodukt: Glycerylanthranilat und Verfahren zur Herstellung desselben
BE828003A (fr) Nouveaux derives d'acides amidocarboxyliques aromatiques
CN113651715B (zh) 一种一锅法合成香豆酰多巴胺的方法
JPH04360879A (ja) 芳香族トリアゾール類の精製方法
EP0124407B1 (de) Verfahren zur Herstellung von Alkansäuren
HUT58734A (en) Optical separating process for producing 3r/3-carboxy-benzyl/-6-/5-fluoro-2-benzothiazolyl/-methoxy-4r-chromanol
FR2468605A1 (fr) Procede de preparation d'ester de l'acide apovincaminique
FR2472571A1 (fr) Procede pour la preparation de derives d'esters halogeno-vincaminiques et halogeno-apovincaminiques
EP0005653B1 (de) Verfahren zur Herstellung von 24,25-Dihydroxy-Cholesterol aus Desmosterol
FR2482966A1 (fr) 1, 2, 3, 4, 4a, 9b, -hexahydro 4-amino dibenzofurannes, leur procede de preparation et leur application en therapeutique
CH638210A5 (fr) Ester derive de l'acide quinolopyranne-4-one-2-carboxylique, procede de sa preparation et utilisation de cet ester comme compose actif dans un medicament antiallergique pour le traitement de l'asthme.
FR2830251A1 (fr) Procede de synthese de l'acide chicorique
FR2472569A1 (fr) 1,2,3,4,4a,9b-hexahydro 4-hydroxy dibenzofurannes et leur procede de preparation
JPS6213936B2 (de)
EP0082057A2 (de) Verfahren zur Herstellung von Phosphinamiden, Anwendungen und Produkte
BE862384A (fr) Derives de la pyrimidoquinoxaline, procede pour leur preparation et medicament en contenant pour le traitement de l'asthme
BE636675A (de)
CH477435A (fr) Procédé de préparation de nouveaux dérivés flavoniques

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): BE CH DE GB LU NL SE

17P Request for examination filed
GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Designated state(s): BE CH DE GB LU NL SE

REF Corresponds to:

Ref document number: 2860803

Country of ref document: DE

Date of ref document: 19811001

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19910708

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 19910712

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LU

Payment date: 19910717

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19910722

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19910723

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19910731

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 19910809

Year of fee payment: 14

EPTA Lu: last paid annual fee
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19920718

Ref country code: GB

Effective date: 19920718

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Effective date: 19920719

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Effective date: 19920731

Ref country code: BE

Effective date: 19920731

BERE Be: lapsed

Owner name: PIERRE FABRE S.A.

Effective date: 19920731

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Effective date: 19930201

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee
GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 19920718

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Effective date: 19930401

EUG Se: european patent has lapsed

Ref document number: 78400060.6

Effective date: 19930204

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT